<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1147" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1147/" /><meta name="ncbi_pagename" content="Familial Exudative Vitreoretinopathy, Autosomal Dominant - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Familial Exudative Vitreoretinopathy, Autosomal Dominant - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Familial Exudative Vitreoretinopathy, Autosomal Dominant" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2011/09/22" /><meta name="citation_author" content="Carmel Toomes" /><meta name="citation_author" content="Louise Downey" /><meta name="citation_pmid" content="20301326" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1147/" /><meta name="citation_keywords" content="adFEVR" /><meta name="citation_keywords" content="adFEVR" /><meta name="citation_keywords" content="Frizzled-4" /><meta name="citation_keywords" content="Low-density lipoprotein receptor-related protein 5" /><meta name="citation_keywords" content="Tetraspanin-12" /><meta name="citation_keywords" content="FZD4" /><meta name="citation_keywords" content="LRP5" /><meta name="citation_keywords" content="TSPAN12" /><meta name="citation_keywords" content="Familial Exudative Vitreoretinopathy, Autosomal Dominant" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Familial Exudative Vitreoretinopathy, Autosomal Dominant" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Carmel Toomes" /><meta name="DC.Contributor" content="Louise Downey" /><meta name="DC.Date" content="2011/09/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1147/" /><meta name="description" content="Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is characterized by failure of peripheral retinal vascularization. The visual problems and variable phenotype associated with adFEVR result from secondary complications caused by retinal ischemia. The retinal avascularity is probably present from birth and generates sequelae that stabilize in early adult life or progress in later life. Expressivity may be asymmetric and is highly variable, ranging from mild or asymptomatic to severe (e.g., registered as blind) within the same family." /><meta name="og:title" content="Familial Exudative Vitreoretinopathy, Autosomal Dominant" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is characterized by failure of peripheral retinal vascularization. The visual problems and variable phenotype associated with adFEVR result from secondary complications caused by retinal ischemia. The retinal avascularity is probably present from birth and generates sequelae that stabilize in early adult life or progress in later life. Expressivity may be asymmetric and is highly variable, ranging from mild or asymptomatic to severe (e.g., registered as blind) within the same family." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1147/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fevr/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1147/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88EFBEE040D1D10000000004090178.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1147_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1147_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fhm/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1147_"><span class="title" itemprop="name">Familial Exudative Vitreoretinopathy, Autosomal Dominant</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: adFEVR</div><p class="contrib-group"><span itemprop="author">Carmel Toomes</span>, PhD, BSc and <span itemprop="author">Louise Downey</span>, PhD, BSc, MBChB, FRCOphth.</p><a data-jig="ncbitoggler" href="#__NBK1147_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1147_ai__"><div class="contrib half_rhythm"><span itemprop="author">Carmel Toomes</span>, PhD, BSc<div class="affiliation small">Royal Society Principal Research Fellow<br />Honorary Associate Professor<br />Section of Ophthalmology and Neuroscience<br />Leeds Institute of Molecular Medicine<br />University of Leeds<br />Leeds, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.sdeel@semoot.c" class="oemail">ku.ca.sdeel@semoot.c</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Louise Downey</span>, PhD, BSc, MBChB, FRCOphth<div class="affiliation small">Consultant in Ophthalmology<br />Hull Royal Infirmary<br />Kingston upon Hull, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@esiuolyenwod" class="oemail">moc.liamtoh@esiuolyenwod</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 21, 2005</span>; Last Revision: <span itemprop="dateModified">September 22, 2011</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fevr.Summary" itemprop="description"><h2 id="_fevr_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) is characterized by failure of peripheral retinal vascularization. The visual problems and variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with adFEVR result from secondary complications caused by retinal ischemia. The retinal avascularity is probably present from birth and generates sequelae that stabilize in early adult life or progress in later life. Expressivity may be asymmetric and is highly variable, ranging from mild or asymptomatic to severe (e.g., registered as blind) within the same family.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of adFEVR is based on a family history compatible with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance and bilateral peripheral retinal avascularity, seen temporally, by indirect ophthalmoscope and scleral indentation, or by fundus fluorescein angiography. Pathogenic variants in one of three genes are known to be associated with adFEVR: <i>FZD4</i>, encoding the protein frizzled-4; <i>LRP5</i>, encoding low-density lipoprotein receptor-related protein 5; and <i>TSPAN12</i>, encoding tetraspanin-12. Pathogenic variants in these genes are responsible for fewer than 50% of adFEVR cases. Another <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, EVR3, has been mapped; the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is not known.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Prophylactic cryotherapy or argon laser photocoagulation to induce regression of new vessel growth caused by ischemia resulting from retinal avascularity; treatment is similar for retinal holes and areas of retinal exudate to prevent retinal detachment; rhegmatogenous retinal detachments produced by retinal traction are repaired surgically using conventional methods and exudative retinal detachments may be stabilized with cryotherapy, but prognosis is guarded for both.</p><p><i>Prevention of secondary complications:</i> Reduced bone density would be expected to benefit from drugs used to treat osteoporosis; however, long-term follow-up data are not yet available.</p><p><i>Surveillance:</i> Regular fundus examination in children to evaluate for neovascularization, traction, or exudate; review of individuals with retinal traction at intervals determined by the clinical findings.</p><p><i>Evaluation of relatives at risk:</i> Fundus examination and fundus fluorescein angiography to identify characteristic lesions to allow early treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Autosomal dominant FEVR is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are at a 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, but many individuals with adFEVR can be asymptomatic because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Prenatal testing is possible if the pathogenic variant has been identified in the family.</p></div></div><div id="fevr.Diagnosis"><h2 id="_fevr_Diagnosis_">Diagnosis</h2><div id="fevr.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) is based on the following:</p><ul><li class="half_rhythm"><div>Family history compatible with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li><li class="half_rhythm"><div>Bilateral peripheral retinal avascularity (<a class="figpopup" href="/books/NBK1147/figure/fevr.F1/?report=objectonly" target="object" rid-figpopup="figfevrF1" rid-ob="figobfevrF1">Figure 1</a>)</div><ul><li class="half_rhythm"><div>Retinal avascularity is usually seen temporally, but may be missed unless an indirect ophthalmoscope and scleral indentation are used.</div></li><li class="half_rhythm"><div>Retinal vascular changes may be more apparent with fundus fluorescein angiography; one small study has suggested that this method identifies 100% of FEVR cases [<a class="bk_pop" href="#fevr.REF.ober.1980.112">Ober et al 1980</a>].</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfevrF1" co-legend-rid="figlgndfevrF1"><a href="/books/NBK1147/figure/fevr.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figfevrF1" rid-ob="figobfevrF1"><img class="small-thumb" src="/books/NBK1147/bin/fevr-Image001.gif" src-large="/books/NBK1147/bin/fevr-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndfevrF1"><h4 id="fevr.F1"><a href="/books/NBK1147/figure/fevr.F1/?report=objectonly" target="object" rid-ob="figobfevrF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Classic features of FEVR 1A. Fundus fluorescein angiogram showing the temporal retinal periphery of the right eye of a mildly affected person. Black areas to the left of the photograph represent loss of the normal capillary architecture corresponding <a href="/books/NBK1147/figure/fevr.F1/?report=objectonly" target="object" rid-ob="figobfevrF1">(more...)</a></p></div></div><p>Other retinal abnormalities that support the diagnosis:</p><ul><li class="half_rhythm"><div>Retinal neovascularization and peripheral brush border anastomoses</div></li><li class="half_rhythm"><div>Peripheral fibrovascular mass</div></li><li class="half_rhythm"><div>Retinal holes/tears that may be associated with retinal detachment</div></li><li class="half_rhythm"><div>Retinal traction (with macular ectopia and/or straightening of vessels at the posterior pole, acute-angle vascular branching) that may be associated with retinal detachment</div></li><li class="half_rhythm"><div>Exudation that may be associated with retinal detachment</div></li><li class="half_rhythm"><div>Falciform retinal folds</div></li></ul><p>Rare retinal features:</p><ul><li class="half_rhythm"><div>Retinoschisis</div></li><li class="half_rhythm"><div>Giant retinal tears</div></li></ul><p>No characteristic electrophysiologic features have been identified.</p></div><div id="fevr.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Genes.</b> To date, pathogenic variants in one of three genes are known to be associated with adFEVR:</p><ul><li class="half_rhythm"><div><i>FZD4</i>, encoding the protein frizzled-4 [<a class="bk_pop" href="#fevr.REF.robitaille.2002.326">Robitaille et al 2002</a>]</div></li><li class="half_rhythm"><div><i>LRP5</i>, encoding low-density lipoprotein receptor-related protein 5 [<a class="bk_pop" href="#fevr.REF.toomes.2004a.721">Toomes et al 2004a</a>]</div></li><li class="half_rhythm"><div><i>TSPAN12,</i> encoding tetraspanin-12 [<a class="bk_pop" href="#fevr.REF.poulter.2010.248">Poulter et al 2010</a>, <a class="bk_pop" href="#fevr.REF.nikopoulos.2010a.240">Nikopoulos et al 2010a</a>]</div></li></ul><p>The proportion of adFEVR attributed to pathogenic variants in each of the genes varies by study:</p><ul><li class="half_rhythm"><div><b><i>FZD4.</i></b> In the original <i>FZD4</i> identification study, pathogenic variants were identified in 40% (2/5) of cases [<a class="bk_pop" href="#fevr.REF.robitaille.2002.326">Robitaille et al 2002</a>]. Most <i>FZD4</i> screening studies have found <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> rates of between 20%-40% although a few studies have found much lower detection rates. Major studies are listed below:</div><ul><li class="half_rhythm"><div>20% (5/24) [<a class="bk_pop" href="#fevr.REF.kondo.2003.1291">Kondo et al 2003</a>]</div></li><li class="half_rhythm"><div>20% (8/40) [<a class="bk_pop" href="#fevr.REF.toomes.2004b.2083">Toomes et al 2004b</a>]</div></li><li class="half_rhythm"><div>7% (1/13) [<a class="bk_pop" href="#fevr.REF.macdonald.2005.363">MacDonald et al 2005</a>]</div></li><li class="half_rhythm"><div>3% (2/56) [<a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>]</div></li><li class="half_rhythm"><div>3% (3/53) [<a class="bk_pop" href="#fevr.REF.nallathambi.2006.1086">Nallathambi et al 2006</a>]</div></li><li class="half_rhythm"><div>14% (9/63) [<a class="bk_pop" href="#fevr.REF.drenser.2009.1649">Drenser et al 2009</a>]</div></li><li class="half_rhythm"><div>40% (8/20) [<a class="bk_pop" href="#fevr.REF.boonstra.2009.4379">Boonstra et al 2009</a>]</div></li><li class="half_rhythm"><div>31% (5/16) [<a class="bk_pop" href="#fevr.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</a>]</div></li><li class="half_rhythm"><div>31% (15/48) [<a class="bk_pop" href="#fevr.REF.jia.2010.1341">Jia et al 2010</a>]</div></li><li class="half_rhythm"><div>17% (12/68) [<a class="bk_pop" href="#fevr.REF.robitaille.2011.574">Robitaille et al 2011</a>]</div></li></ul></li><li class="half_rhythm"><div><b><i>LRP5.</i></b> In the original <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> identification study, <i>LRP5</i> pathogenic variants were responsible for 18% (6/32) of cases [<a class="bk_pop" href="#fevr.REF.toomes.2004a.721">Toomes et al 2004a</a>]. Further studies have found <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> rates between 10% and 25% (7/56, 2/20 and 4/16) [<a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>, <a class="bk_pop" href="#fevr.REF.boonstra.2009.4379">Boonstra et al 2009</a>, <a class="bk_pop" href="#fevr.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</a>].</div></li><li class="half_rhythm"><div><b><i>TSPAN12.</i></b> Two teams identified <i>TSPAN12</i>. In the study by Poulter et al pathogenic variants were detected in 10% (7/70) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. This figure is likely to be high as the cohort screened in this study had already been screened for pathogenic variants in the other FEVR-related genes [<a class="bk_pop" href="#fevr.REF.poulter.2010.248">Poulter et al 2010</a>]. In the study by Nikopoulos et al pathogenic variants were detected in 45% (5/11) of individuals. This figure is probably not a true reflection of <i>TSPAN12</i> variant frequency as the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was detected in four of these families, indicating the presence of a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>. Only one subsequent study has been undertaken, showing a detection rate of 3% (3/90) [<a class="bk_pop" href="#fevr.REF.kondo.2011.1095">Kondo et al 2011</a>].</div></li></ul><p><b>Evidence for further <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity.</b> A fourth locus for adFEVR, EVR3 (chromosomal locus 11p12-p13), has been mapped; the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is not yet known [<a class="bk_pop" href="#fevr.REF.downey.2001.778">Downey et al 2001</a>].</p><p><b>Clinical testing</b></p><ul><li class="half_rhythm"><div><b><i>FZD4.</i></b> Sequence analysis of <i>FZD4</i> has identified various types of pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, small deletions, small insertions); no splice variants have been reported. The pathogenic variants appear to be evenly distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. No mutational hot spots have been identified.</div></li><li class="half_rhythm"><div><b><i>LRP5.</i></b> Sequence analysis of <i>LRP5</i> has identified many types of pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, small deletions, small insertions, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>). The pathogenic variants appear to be evenly distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. No mutational hot spots have been identified. Each <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> appears to be family specific.</div></li><li class="half_rhythm"><div><b><i>TSPAN12.</i></b> Sequence analysis of <i>TSPAN12</i> has identified all types of pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, small deletions, small insertions, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>). The pathogenic variants appear to be evenly distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. No mutational hot spots have been identified. Each <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> appears to be family specific with the exception of <a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_tspan12_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figfevrTselectedtspan12pathogenicvaria" rid-ob="figobfevrTselectedtspan12pathogenicvaria">c.709G&#x0003e;C</a> (p.Ala237Pro), which is common in the Netherlands.</div></li></ul><div id="fevr.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Familial Exudative Vitreoretinopathy, Autosomal Dominant</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of adFEVR Attributed to Pathogenic Variants in Gene</th><th id="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FZD4</i></td><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%-40%</td><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRP5</i></td><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%-25%</td></tr><tr><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TSPAN12</i></td><td headers="hd_h_fevr.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%-10%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fevr.TF.1.1"><p class="no_margin">See <a href="/books/NBK1147/#fevr.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="fevr.TF.1.2"><p class="no_margin">See <a href="#fevr.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="fevr.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected.For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd></dl></div></div></div></div><div id="fevr.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The diagnosis of adFEVR is based on a family history compatible with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance and bilateral peripheral retinal avascularity, seen temporally, by indirect ophthalmoscope and scleral indentation, or by fundus fluorescein angiography.</div></li><li class="half_rhythm"><div>Molecular genetic testing should begin with <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>FZD4.</i></div></li><li class="half_rhythm"><div>If a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>LRP5</i> should be performed.</div></li><li class="half_rhythm"><div>If a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TSPAN12</i> should be performed.</div></li><li class="half_rhythm"><div>Because not all genes associated with adFEVR are known, failure to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FZD4</i>, <i>LRP5</i> or <i>TSPAN1</i>2 does not rule out the diagnosis.</div></li></ul></div></div><div id="fevr.Clinical_Characteristics"><h2 id="_fevr_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fevr.Clinical_Description"><h3>Clinical Description</h3><p>All individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) have failure of peripheral retinal vascularization, which by itself usually causes no clinical symptoms. The visual problems and variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with adFEVR result from secondary complications caused by retinal ischemia. This region of retinal avascularity is presumed to be present from birth and initially was thought to generate sequelae that stabilized in early adult life [<a class="bk_pop" href="#fevr.REF.ober.1980.112">Ober et al 1980</a>, <a class="bk_pop" href="#fevr.REF.tasman.1981.211">Tasman et al 1981</a>]. Later studies suggested that disease may progress into later life [<a class="bk_pop" href="#fevr.REF.shukla.2003.323">Shukla et al 2003</a>].</p><p>Autosomal dominant FEVR shows highly <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and may be markedly asymmetric. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> ranges from mild to severe even within the same family. At the mild end of the spectrum, individuals are asymptomatic; at the severe end, children are registered as blind shortly after birth.</p><p>Forty-one percent of the individuals reported by <a class="bk_pop" href="#fevr.REF.shukla.2003.323">Shukla et al [2003]</a> were at the mild end of the spectrum, in which vision is normal; the only manifestation was an asymptomatic sector of peripheral retinal avascularity. A proportion of individuals demonstrate retinal exudates and retinal traction; about 20% develop rhegmatogenous retinal detachment [<a class="bk_pop" href="#fevr.REF.miyakubo.1984.1524">Miyakubo et al 1984</a>, <a class="bk_pop" href="#fevr.REF.van_nouhuys.1991.34">van Nouhuys 1991</a>]. Individuals with this severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> often present in the first ten years of life with reduced vision, strabismus, and/or leukocoria.</p><p>Individuals with adFEVR and pathogenic variants in <i>LRP5</i> have been observed to have reduced bone mass [<a class="bk_pop" href="#fevr.REF.toomes.2004a.721">Toomes et al 2004a</a>, <a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>]. Preliminary studies indicate that this finding is not seen in individuals with FEVR who have <i>FZD4</i> pathogenic variants or those with other forms of FEVR [<a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>; Toomes, personal communication]. Reduced bone mass is often evident only upon examination and predisposes <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to bone fractures.</p></div><div id="fevr.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Although the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has appeared to be indistinguishable by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved, research suggests that individuals with adFEVR who have pathogenic variants within <i>LRP5</i> may show signs of osteopenia or osteoporosis on dual x-ray absorptiometry (DXA) [<a class="bk_pop" href="#fevr.REF.toomes.2004a.721">Toomes et al 2004a</a>, <a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>].</p><p><b>Possible complex inheritance of FEVR.</b> A family with pathogenic variants in both <i>FZD4</i> (<a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedfzd4pathogenicvariants" rid-ob="figobfevrTselectedfzd4pathogenicvariants">c.1250G&#x0003e;A</a>; p.Arg417Gln) and <i>LRP5</i> (<a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_lrp5_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedlrp5pathogenicvariants" rid-ob="figobfevrTselectedlrp5pathogenicvariants">c.1330C&#x0003e;T</a>; p.Arg444Cys) in <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> configuration on the same <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> had a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than another unrelated family with the same <i>FZD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> only [<a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>]. Three of four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members with both pathogenic variants were blind, whereas three of four affected family members with only the <i>FZD4</i> pathogenic variant were asymptomatic. These findings suggest synergy between the <i>FZD4</i> pathogenic variant (p.Arg417Gln) and the <i>LRP5</i> pathogenic variant (p.Arg444Cys) in the adFEVR phenotype [<a class="bk_pop" href="#fevr.REF.qin.2005.104">Qin et al 2005</a>].</p><p>In a family with FEVR with an <i>FZD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedfzd4pathogenicvariants" rid-ob="figobfevrTselectedfzd4pathogenicvariants">c.1463G&#x0003e;A</a> (p.Gly488Asp), one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had an <i>FZD4</i> sequence variant <a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedfzd4pathogenicvariants" rid-ob="figobfevrTselectedfzd4pathogenicvariants">c.205C&#x0003e;T</a> (p.His69Tyr) in <a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a> configuration associated with a more severe ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than that in family members with the p.Gly488Asp pathogenic variant only [<a class="bk_pop" href="#fevr.REF.kondo.2003.1291">Kondo et al 2003</a>]. This p.His69Tyr variant was also found in controls and in another family with adFEVR [<a class="bk_pop" href="#fevr.REF.omoto.2004.81">Omoto et al 2004</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> of the family reported by <a class="bk_pop" href="#fevr.REF.omoto.2004.81">Omoto et al [2004]</a> had a severe phenotype at age six years, while her affected mother and brother had a mild subclinical form of the disease.</p><p>Early data suggesting that the <a href="/books/n/gene/factor-v-leiden/">factor V Leiden</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> could be modifying the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was not supported by subsequent studies. The cosegregation of an <i>FZD4</i> pathogenic variant <a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedfzd4pathogenicvariants" rid-ob="figobfevrTselectedfzd4pathogenicvariants">c.1502delCT</a> and the factor V Leiden variant in a family with a severe adFEVR phenotype suggested that the factor V Leiden variant could be modifying the phenotype [<a class="bk_pop" href="#fevr.REF.shastry.2004.79">Shastry &#x00026; Trese 2004</a>]. However, the report of a second family with the same <i>FZD4</i> pathogenic variant and a severe FEVR phenotype but without the Leiden pathogenic variant [<a class="bk_pop" href="#fevr.REF.bottomley.2006.6">Bottomley et al 2006</a>] suggested that the cosegregation of these two variants in the first family was the result of chance alone. This conclusion was further supported by the failure of <a class="bk_pop" href="#fevr.REF.bottomley.2006.6">Bottomley et al [2006]</a> to identify a factor V Leiden variant in 14 additional families with adFEVR.</p></div><div id="fevr.Penetrance"><h3>Penetrance</h3><p>When using fluorescein angiography to determine clinical status, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is reported to be 100% because all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a sector of avascular peripheral retina [<a class="bk_pop" href="#fevr.REF.ober.1980.112">Ober et al 1980</a>].</p><p>Using examination of the retina with an indirect ophthalmoscope through a dilated pupil to determine clinical status, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is considered to be about 90% [<a class="bk_pop" href="#fevr.REF.van_nouhuys.1982.1">van Nouhuys 1982</a>].</p><p>Using reduced vision or other clinical symptoms to determine clinical status, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> as low as 10% is reported.</p></div><div id="fevr.Prevalence"><h3>Prevalence</h3><p>FEVR is often described as a very rare disorder. The prevalence has not been calculated; however, given that molecular testing has shown that as many as 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be asymptomatic, it is likely that the frequency of the disorder is underestimated.</p><p>FEVR has been described in all ethnic groups.</p></div></div><div id="fevr.Genetically_Related_Allelic_Disorde"><h2 id="_fevr_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Mutation of <i>LRP5</i> is known to cause two <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders:</p><ul><li class="half_rhythm"><div>Autosomal recessive FEVR (arFEVR) [<a class="bk_pop" href="#fevr.REF.shastry.1997.217">Shastry &#x00026; Trese 1997</a>, <a class="bk_pop" href="#fevr.REF.de_crecchio.1998.315">de Crecchio et al 1998</a>, <a class="bk_pop" href="#fevr.REF.jiao.2004.878">Jiao et al 2004</a>]</div></li><li class="half_rhythm"><div>Osteoporosis-pseudoglioma syndrome (OPPG) (OMIM <a href="http://omim.org/entry/259770" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">259770</a>) [<a class="bk_pop" href="#fevr.REF.gong.2001.513">Gong et al 2001</a>]</div></li></ul><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants within the first few exons of <i>LRP5</i> have been described in the following <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorders characterized by high bone mass:</p><ul><li class="half_rhythm"><div>High bone mass (OMIM <a href="http://omim.org/entry/601884" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601884</a>)</div></li><li class="half_rhythm"><div>Endosteal hyperostosis (OMIM <a href="http://omim.org/entry/144750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">144750</a>)</div></li><li class="half_rhythm"><div>Osteopetrosis (OMIM <a href="http://omim.org/entry/607634" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607634</a>) [<a class="bk_pop" href="#fevr.REF.boyden.2002.1513">Boyden et al 2002</a>, <a class="bk_pop" href="#fevr.REF.little.2002.11">Little et al 2002</a>, <a class="bk_pop" href="#fevr.REF.van_wesenbeeck.2003.763">Van Wesenbeeck et al 2003</a>]</div></li></ul></div><div id="fevr.Differential_Diagnosis"><h2 id="_fevr_Differential_Diagnosis_">Differential Diagnosis</h2><p>Familial exudative vitreoretinopathy (FEVR) can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> cannot be distinguished by clinical examination alone.</p><ul><li class="half_rhythm"><div><b>Autosomal dominant FEVR</b> is the most common of the three modes of inheritance.</div></li><li class="half_rhythm"><div><b>Autosomal recessive FEVR</b> is caused by pathogenic variants in <i>LRP5</i> [<a class="bk_pop" href="#fevr.REF.shastry.1997.217">Shastry &#x00026; Trese 1997</a>, <a class="bk_pop" href="#fevr.REF.de_crecchio.1998.315">de Crecchio et al 1998</a>, <a class="bk_pop" href="#fevr.REF.jiao.2004.878">Jiao et al 2004</a>] (see <a href="#fevr.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</div></li><li class="half_rhythm"><div><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> FEVR</b> is one of the <a href="/books/n/gene/norrie/"><i>NDP</i>-related retinopathies</a>, a range of phenotypes caused by pathogenic variants in <i>NDP</i> that includes X-linked FEVR [<a class="bk_pop" href="#fevr.REF.chen.1993.180">Chen et al 1993</a>] and Norrie disease.</div></li></ul><p><a href="/books/n/gene/i-p/">Incontinentia pigmenti</a> (IP) is a rare <a class="def" href="/books/n/gene/glossary/def-item/x-linked-dominant/">X-linked dominant</a> disorder affecting the skin, hair, teeth, nails, and eyes. The eye <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is present in one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and resembles FEVR. The other findings of IP distinguish it from FEVR.</p><p>Acquired disorders that resemble adFEVR:</p><ul><li class="half_rhythm"><div><b>Retinopathy of prematurity (ROP),</b> a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> disorder, is the best phenocopy for FEVR. ROP is characterized by failure of the peripheral retinal vasculature to develop, partly as a result of premature birth prior to the completion of retinal vascularization. In some infants with ROP, retinal neovascularization and cicatricial sequelae appear similar to those seen in individuals with FEVR. The history of prematurity and the lack of a family history of FEVR help to distinguish ROP from FEVR.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/norrie/"><b>Coats disease, persistent fetal vasculature syndrome</b></a><b>,</b> and <b>toxocariasis</b> have distinctive clinical pictures that may resemble features of the FEVR <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, including peripheral retinal fibrovascular mass, retrolental membranes, and exudative detachment.</div><ul><li class="half_rhythm"><div><b>Coats disease</b> (OMIM <a href="http://omim.org/entry/300216" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300216</a>) is characterized by severe retinal telangiectasia. Abnormal vessels can be present throughout the fundus, producing massive exudates that may lead to retinal detachment. It is commonly seen unilaterally in boys.</div></li><li class="half_rhythm"><div><b>Persistent fetal vasculature syndrome or persistent hyperplastic primary vitreous (PHPV)</b> is characterized by retrolental fibrovascular membranes reminiscent of Norrie disease (see <a href="/books/n/gene/norrie/"><i>NDP</i>-Related Retinopathies</a>). It is observed in full-term infants and is attributed to failure of regression of the hyaloid vasculature. Involvement is usually unilateral but can be bilateral. Occurrence is usually <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> but occasionally <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>. In contrast to FEVR, the involved eyes are often microphthalmic. Clinical features of abnormal hyaloid artery regression, the physiologic process thought to underlie PHPV, are also seen in some persons with FEVR. In one family with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> FEVR, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members had a tuft of gliotic tissue at the disc (Bergmeister's papillae) or central vitreous opacity extending from the posterior pole to the lens suggestive of a persistent hyaloid artery [<a class="bk_pop" href="#fevr.REF.downey.2006.1163">Downey et al 2006</a>].</div></li><li class="half_rhythm"><div><b>Toxocariasis</b> is an acquired, usually unilateral, infestation with the round-worm <i>Toxocara canis</i>. In one form, a peripheral granulomatous mass develops. Retinal traction may ensue, forming a retinal fold. The uveitis that can be associated with toxocariasis is not a feature of FEVR.</div></li></ul></li></ul></div><div id="fevr.Management"><h2 id="_fevr_Management_">Management</h2><div id="fevr.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Ophthalmologic examination, including indirect ophthalmoscopy and scleral depression</div></li><li class="half_rhythm"><div>Fundus fluorescein angiography, which increases the detection rate of peripheral avascularity in asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#fevr.REF.ober.1980.112">Ober et al 1980</a>]</div></li></ul></div><div id="fevr.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Retinal avascularity per se often requires no treatment; however, it can induce ischemia, leading to neovascularization of the retinal periphery, which can be treated with prophylactic cryotherapy or argon laser photocoagulation to attempt to induce regression of the new vessels. Similar treatments are used to treat retinal holes and areas of retinal exudate to prevent retinal detachment.</p><p>Rhegmatogenous retinal detachments produced by retinal traction are repaired surgically using conventional methods, but the prognosis is guarded.</p><p>Exudative retinal detachments may be stabilized with cryotherapy, but the prognosis is poor.</p></div><div id="fevr.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>The arc of peripheral retinal avascularity, thought to be an aberration of retinal development, is not preventable using current treatments.</p></div><div id="fevr.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Patients with FEVR associated with reduced bone density would be expected to benefit from drugs used to treat osteoporosis, although long-term data demonstrating an increase in bone density in these patients is not yet available [<a class="bk_pop" href="#fevr.REF.downey.2006.1163">Downey et al 2006</a>].</p></div><div id="fevr.Surveillance"><h3>Surveillance</h3><p>Children who are at risk based on family history should undergo regular fundus examination to evaluate for the development of retinal neovascularization, traction, or exudate.</p><p>Asymptomatic individuals with a small region of peripheral avascularity may require annual review only. Those with active neovascularization or exudate may well require treatment and close observation thereafter.</p><p>Individuals with retinal traction require review at intervals depending on the degree of stability of the clinical findings. The frequency of the review varies by individual depending on the assessment of the examining clinician.</p></div><div id="fevr.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Relatives at risk benefit from fundus examination and, ideally, fundus fluorescein angiography to identify any characteristic lesions. Prophylaxis in the form of peripheral retinal ablation with laser photocoagulation or cryotherapy depends on the individual's age and the progression of the lesion.</p><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk family members may be useful: relatives who do not have the family-specific pathogenic variant do not need regular retinal examinations.</p><p>See <a href="#fevr.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fevr.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Vascular endothelial growth factor (VEGF) inhibitors are currently in widespread use for acquired retinal diseases with a neovascular or exudative component. An as-yet unpublished study presented information on six children with FEVR and sight-threatening retinal neovascularization and exudate who had failed to stabilize with conventional treatments [<a class="bk_pop" href="#fevr.REF.drenser.2006">Drenser 2006</a>]. Treatment with pegaptanib sodium intravitreal injection resulted in a sustained decrease in exudate over six months; however, retinal traction continued to progress; in some eyes this appeared to be initiated by VEGF inhibition. The long-term effects of VEGF inhibition on the eye and the effects of VEGF inhibition in a pediatric population are currently unknown.</p><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="fevr.Genetic_Counseling"><h2 id="_fevr_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fevr.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="fevr.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with adFEVR have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent who may or may not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div><ul><li class="half_rhythm"><div>Because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, it is common for such parents to have no visual complications and thus be undiagnosed.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be in an (as-yet) unidentified <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</div></li></ul></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with adFEVR may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is currently unknown.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include examination by fundus fluorescein angiography and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if a pathogenic variant has been identified in the family.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%.</div><ul><li class="half_rhythm"><div>If the sib inherits the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it is not possible to predict whether symptoms will occur. If symptoms do occur, it is not possible to predict the age of onset or severity of symptoms.</div></li><li class="half_rhythm"><div>Initial studies have shown that up to 90% of individuals with adFEVR can be asymptomatic.</div></li></ul></li><li class="half_rhythm"><div>If a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and both parents have normal findings on fundus fluorescein angiography, the risk to the sibs of a proband for adFEVR is low.</div></li><li class="half_rhythm"><div>Although no instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with adFEVR has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the offspring inherits the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it is not possible to predict whether symptoms will occur. If symptoms do occur, it is not possible to predict the age of onset or severity.</div></li><li class="half_rhythm"><div>Up to 90% of individuals with adFEVR can be asymptomatic.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents. If a parent has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="fevr.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#fevr.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Possible complex inheritance of FEVR.</b> While no conclusive evidence is available, some anecdotal findings suggest that the pattern of inheritance of FEVR may be more complex than previously thought (see <a href="#fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p><b>Genetic counseling for disorders with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</b> Reduced penetrance and the likelihood of additional (as-yet unidentified) genes associated with adFEVR result in significant difficulty in determining which at-risk family members have and have not inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Early studies suggested that approximately 50% of individuals with adFEVR were asymptomatic [<a class="bk_pop" href="#fevr.REF.benson.1995.473">Benson 1995</a>]; however, based on limited data from molecular testing for asymptomatic at-risk family members in research studies, this figure appears to be much higher, perhaps as high as 90%. Additional studies may identify penetrance to be variant specific.</p><p><b>Genetic counseling for disorders with genetic heterogeneity.</b> Because the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, and <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> forms of FEVR cannot be distinguished by ophthalmologic examination alone, determining the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> for a particular family can be difficult, and for the <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case, may not be possible.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder and/or the pathogenic variant, it is possible that the proband has a <i>de novo</i> pathogenic variant or the parent has reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fevr.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="fevr.Resources"><h2 id="_fevr_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li><li class="half_rhythm"><div><b>Retina International</b></div><div>Retina Suisse</div><div>Ausstellungsstrasse 36</div><div> Zurich CH-8005</div><div>Switzerland</div><div><b>Phone:</b> +41 (0) 44 444 1077</div><div><b>Fax:</b> +41 (0) 44 444 1070</div><div><b>Email:</b> christina.fasser@retina-international.org</div><div><a href="http://www.retina-international.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.retina-international.org</a></div></li><li class="half_rhythm"><div><b>American FEVR Research Consortium Registry</b></div><div>Moran Eye Center, University of Utah</div><div>65 Medical Drive</div><div>Room 6620-C</div><div>Salt Lake City UT 84112</div><div><b>Phone:</b> 800-824-2073 ext 51297; 801-585-1297</div><div><b>Fax:</b> 801-587-7686</div><div><b>Email:</b> jennifer.harmon@hsc.utah.edu</div></li><li class="half_rhythm"><div><b>eyeGENE - National Ophthalmic Disease Genotyping Network Registry</b></div><div><b>Phone:</b> 301-435-3032</div><div><b>Email:</b> eyeGENEinfo@nei.nih.gov</div><div><a href="https://eyegene.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nei.nih.gov/eyegene</a></div></li></ul></div><div id="fevr.Molecular_Genetics"><h2 id="_fevr_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fevr.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Familial Exudative Vitreoretinopathy, Autosomal Dominant: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fevr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_fevr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fevr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fevr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fevr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_fevr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fevr.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fevr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">EVR1</td><td headers="hd_b_fevr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8322" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FZD4</i></a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8322" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q14<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9ULV1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Frizzled-4</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FZD4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FZD4 database</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FZD4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FZD4</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FZD4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FZD4</a></td></tr><tr><td headers="hd_b_fevr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">EVR4</td><td headers="hd_b_fevr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4041" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LRP5</i></a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4041" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75197" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low-density lipoprotein receptor-related protein 5</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/LRP5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP5 @ LOVD</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LRP5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP5</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LRP5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP5</a></td></tr><tr><td headers="hd_b_fevr.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">EVR5</td><td headers="hd_b_fevr.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23554" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TSPAN12</i></a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23554" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q31<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95859" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tetraspanin-12</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/TSPAN12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TSPAN12 @ LOVD</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TSPAN12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TSPAN12</a></td><td headers="hd_b_fevr.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TSPAN12[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TSPAN12</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fevr.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fevr.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Familial Exudative Vitreoretinopathy, Autosomal Dominant (<a href="/omim/133780,601813,603506,604579,605750,613138,613310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/133780" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">133780</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXUDATIVE VITREORETINOPATHY 1; EVR1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601813" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601813</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXUDATIVE VITREORETINOPATHY 4; EVR4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603506" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603506</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604579" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604579</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRIZZLED CLASS RECEPTOR 4; FZD4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605750" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605750</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXUDATIVE VITREORETINOPATHY 3; EVR3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613138" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613138</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TETRASPANIN 12; TSPAN12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613310</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXUDATIVE VITREORETINOPATHY 5; EVR5</td></tr></tbody></table></div></div><div id="fevr.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The primary pathologic process in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) is believed to be a premature arrest of retinal angiogenesis/vasculogenesis or retinal vascular differentiation, leading to incomplete vascularization of the peripheral retina. To date, pathogenic variants in four genes have been shown to cause FEVR: <i>NDP</i> (encoding norrin) (OMIM <a href="http://omim.org/entry/300658" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300658</a>) (<a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> see <a href="/books/n/gene/norrie/"><i>NDP</i>-Related Disorders</a>), <i>FZD4</i> (dominant), <i>LRP5</i> (dominant and recessive) and <i>TSPAN12</i> (dominant). Each of the encoded proteins is a component of the norrin/&#x003b2;-catenin signaling pathway (also referred to as the norrin/frizzled-4 pathway). In this pathway, the ligand norrin binds to a receptor complex consisting of the receptor frizzled-4, the co-receptor low-density lipoprotein receptor-related protein-5, and the auxiliary protein tetraspanin-12. In the absence of norrin binding, signaling is not activated. This results in cytoplasmic &#x003b2;-catenin becoming phosphorylated and targeted for degradation through the ubiquitin-proteasome pathway. As a result, prospective target genes remain repressed. Signaling is activated by norrin binding to the frizzled-4, LRP5 and TSPAN12 receptor complex. This complex triggers a signal which inhibits the destruction of &#x003b2;-catenin, allowing its cytoplasmic levels to increase. Subsequently, &#x003b2;-catenin enters the nucleus where it interacts with the T-cell factor (TCF)/lymphoid enhancing factor (LEF) family of transcription factors to turn on the expression of norrin target genes. This signaling pathway shares many similarities to the canonic Wnt/&#x003b2;-catenin pathway except that norrin substitutes Wnt as the ligand and no tetraspanins have been linked to Wnt/&#x003b2;-catenin signaling. Identifying new FEVR-related genes therefore provides an ideal opportunity to discover new components of this important signaling pathway [<a class="bk_pop" href="#fevr.REF.xu.2004.883">Xu et al 2004</a>, <a class="bk_pop" href="#fevr.REF.junge.2009.299">Junge et al 2009</a>, <a class="bk_pop" href="#fevr.REF.ye.2010.417">Ye et al 2010</a>].</p><div id="fevr.FZD4"><h4><i>FZD4</i></h4><p><b>Gene structure.</b>
<i>FZD4</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is 7,394 bp long and comprises two exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1147/#fevr.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Types of pathogenic variants identified in <i>FZD4</i> include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> changes, insertions, and deletions; no <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have been identified. The majority of deletions and insertions result in a frameshift error in the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins.</p><div id="fevr.T.selected_fzd4_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>FZD4</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.T.selected_fzd4_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1250G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg417Gln</td><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_012193.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_012193<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_036325.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_036325<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.205C&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His69Tyr</td></tr><tr><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1463G&#x0003e;A</td><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly488Asp</td></tr><tr><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1501_1502delCT</td><td headers="hd_h_fevr.T.selected_fzd4_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu501SerfsTer533</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>).</p></div></dd><dt>1. </dt><dd><div id="fevr.TF.2.1"><p class="no_margin">Associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> when <i>in</i>
<a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> with <i>LRP5</i>
<a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_lrp5_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedlrp5pathogenicvariants" rid-ob="figobfevrTselectedlrp5pathogenicvariants">c.1330C&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see <a href="#fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>, <b>Possible complex inheritance of FEVR</b>).</p></div></dd><dt>2. </dt><dd><div id="fevr.TF.2.2"><p class="no_margin">Associated with a more severe ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> when <i>in</i>
<a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a> with the c.1463G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see <a href="#fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>, <b>Possible complex inheritance of FEVR</b>).</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 537-amino acid protein frizzled-4 is a member of the frizzled family of seven-pass transmembrane receptors that bind Wnt proteins [<a class="bk_pop" href="#fevr.REF.huang.2004.234">Huang &#x00026; Klein 2004</a>]. However, frizzled-4 is the only member of the frizzled family that functions in the norrin/&#x003b2;-catenin pathway. Evidence suggests that this pathway is the one underlying FEVR and is triggered by the binding of norrin rather than a Wnt ligand to a receptor complex comprising frizzled-4, LRP5, and tetraspanin12 [<a class="bk_pop" href="#fevr.REF.xu.2004.883">Xu et al 2004</a>, <a class="bk_pop" href="#fevr.REF.junge.2009.299">Junge et al 2009</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Many of the pathogenic variants in frizzled-4 result in premature termination codons (PTCs). The most likely outcome for pathogenic variants resulting in PTCs is <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> induced by <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay. However, if the PTC is not followed by a downstream <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a>, as is the case for all the frameshift variants identified in frizzled-4, the mRNAs can escape this process, enabling them to be translated into truncated mutant proteins. The precise effect of PTCs on frizzled-4 has not been investigated; thus it is not known whether an abnormal gene product is created. However, a study in which a truncated mutant frizzled-4 protein (p.Leu501fsTer533) was created in vitro showed that the mutant protein is not located in its usual position within the cell membrane but is trapped within the endoplasmic reticulum [<a class="bk_pop" href="#fevr.REF.robitaille.2002.326">Robitaille et al 2002</a>, <a class="bk_pop" href="#fevr.REF.kaykas.2004.52">Kaykas et al 2004</a>]. This mutated protein also trapped the <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> protein within the cell and appeared to act in a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> manner [<a class="bk_pop" href="#fevr.REF.kaykas.2004.52">Kaykas et al 2004</a>].</p><p>The majority of the frizzled-4 pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants appear to be in functional sites, suggesting that they knock out the function of the protein. For example, in vitro experiments have shown that missense variants in the CRD <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (p.Met105Val and p.Met157Val) reduce the ability of frizzled-4 to bind norrin and to activate the &#x003b2;-catenin pathway [<a class="bk_pop" href="#fevr.REF.xu.2004.883">Xu et al 2004</a>].</p></div><div id="fevr.LRP5"><h4><i>LRP5</i></h4><p><b>Gene structure.</b>
<i>LRP5</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is 5,161 bp long and comprises 23 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1147/#fevr.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All types of pathogenic variants have been identified in <i>LRP5</i>: <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> changes, insertions, deletions, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. The majority of deletions, insertions, and splice variants result in a frameshift error in the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins.</p><div id="fevr.T.selected_lrp5_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>LRP5</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.T.selected_lrp5_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.T.selected_lrp5_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.518C&#x0003e;T</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr173Met</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_002335.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002335<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_002326.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002326<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1330C&#x0003e;T</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg444Cys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4081T&#x0003e;G</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys1361Gly</td></tr><tr><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4099G&#x0003e;A</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu1367Lys</td></tr><tr><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3502T&#x0003e;C</td><td headers="hd_h_fevr.T.selected_lrp5_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr1168His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>).</p></div></dd><dt>1. </dt><dd><div id="fevr.TF.3.1"><p class="no_margin">Associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> when <i>in</i>
<a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a> with <i>FZD4</i>
<a class="figpopup" href="/books/NBK1147/table/fevr.T.selected_fzd4_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfevrTselectedfzd4pathogenicvariants" rid-ob="figobfevrTselectedfzd4pathogenicvariants">c.1250G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see <a href="#fevr.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>, <b>Possible complex inheritance of FEVR</b>).</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>LRP5</i> encodes a 1,615-amino acid single-pass transmembrane receptor, termed low-density lipoprotein receptor-related protein 5. It partners with frizzled receptors (e.g., frizzled-4) to bind Wnt proteins [<a class="bk_pop" href="#fevr.REF.he.2004.1663">He et al 2004</a>]. LRP5 also functions in the norrin/&#x003b2;-catenin pathway. Evidence suggests that this pathway is the one underlying FEVR and is triggered by the binding of norrin rather than a Wnt ligand to a receptor complex comprising frizzled-4, LRP5, and tetraspanin12.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>LRP5</i> pathogenic variants identified in individuals with adFEVR are predicted to result in functional <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of the protein. Most <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants are likely to undergo nonsense-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay or produce truncated proteins that are incorrectly transported within the cell; however, no direct evidence exists. In vitro cell-based assays have shown that the adFEVR <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants p.Tyr1168His and p.Cys1361Gly affect the transduction of &#x003b2;-catenin signaling upon binding of either Wnt or norrin. However, two other adFEVR-related variants (p.Thr173Met and p.Glu1367Lys) tested in a similar manner did not show any effect. When proteins with the adFEVR-related variants p.Thr173Met, p.Glu1367Lys, p.Tyr1168His, and p.Cys1361Gly were cotransfected with <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> LRP5 protein, none of them interfered with wild-type Wnt/&#x003b2;-catenin signaling, arguing against a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect for these variants on Wnt signaling [<a class="bk_pop" href="#fevr.REF.ai.2005.741">Ai et al 2005</a>].</p></div><div id="fevr.TSPAN12"><h4><i>TSPAN12</i></h4><p><b>Gene structure.</b>
<i>TSPAN12</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is 2579 bp long and comprises eight exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1147/#fevr.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The types of pathogenic variants identified in <i>TSPAN12</i> include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> changes, insertions, deletions, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. The majority of deletions, insertions, and splice variants result in a frameshift error in the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>, but it is not known whether these aberrant mRNAs are targeted for nonsense-mediated mRNA decay or if they produce prematurely terminated truncated proteins.</p><div id="fevr.T.selected_tspan12_pathogenic_varia" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>TSPAN12</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1147/table/fevr.T.selected_tspan12_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fevr.T.selected_tspan12_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.709G&#x0003e;C</td><td headers="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala237Pro&#x000a0;<sup>1</sup></td><td headers="hd_h_fevr.T.selected_tspan12_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_012338.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_012338<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_036470.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_036470<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>).</p></div></dd><dt>1. </dt><dd><div id="fevr.TF.4.1"><p class="no_margin">Common in the Netherlands</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TSPAN12</i> encodes a 305-amino acid protein containing four transmembrane-spanning domains, termed tetraspanin12. It forms a component of the norrin-LRP5-FZD4 signaling complex; cell-based assays have shown that it enhances the level of norrin/&#x003b2;-catenin signaling [<a class="bk_pop" href="#fevr.REF.junge.2009.299">Junge et al 2009</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>TSPAN12</i> pathogenic variants identified in individuals with adFEVR are predicted to result in functional <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of the protein. Most <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants are predicted to undergo nonsense-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay or produce truncated proteins that are incorrectly transported within the cell.</p></div></div></div><div id="fevr.References"><h2 id="_fevr_References_">References</h2><div id="fevr.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.ai.2005.741">Ai M, Heeger S, Bartels CF, Schelling DK. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:741–53.</span> [<a href="/pmc/articles/PMC1271384/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1271384</span></a>] [<a href="/pubmed/16252235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16252235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.benson.1995.473">Benson WE. Familial exudative vitreoretinopathy. <span><span class="ref-journal">Trans Am Ophthalmol Soc. </span>1995;<span class="ref-vol">93</span>:473–521.</span> [<a href="/pmc/articles/PMC1312071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1312071</span></a>] [<a href="/pubmed/8719692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8719692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.boonstra.2009.4379">Boonstra FN, van Nouhuys CE, Schuil J, de Wijs IJ, van der Donk KP, Nikopoulos K, Mukhopadhyay A, Scheffer H, Tilanus MA, Cremers FP, Hoefsloot LH. Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2009;<span class="ref-vol">50</span>:4379–85.</span> [<a href="/pubmed/19324841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19324841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.bottomley.2006.6">Bottomley HM, Downey LM, Inglehearn CF, Toomes C. Comment on 'cosegregation of two unlinked mutant alleles in some cases of autosomal dominant familial exudative vitreoretinopathy.'. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:6–7.</span> [<a href="/pubmed/16319824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16319824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.boyden.2002.1513">Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. High bone density due to a mutation in LDL-receptor-related protein 5. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">346</span>:1513–21.</span> [<a href="/pubmed/12015390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12015390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.chen.1993.180">Chen ZY, Battinelli EM, Fielder A, Bundey S, Sims K, Breakefield XO, Craig IW. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. <span><span class="ref-journal">Nat Genet. </span>1993;<span class="ref-vol">5</span>:180–3.</span> [<a href="/pubmed/8252044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8252044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.de_crecchio.1998.315">de Crecchio G, Simonelli F, Nunziata G, Mazzeo S, Greco GM, Rinaldi E, Ventruto V, Ciccodicola A, Miano MG, Testa F, Curci A, D'Urso M, Rinaldi MM, Cavaliere ML, Castelluccio P. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. <span><span class="ref-journal">Clin Genet. </span>1998;<span class="ref-vol">54</span>:315–20.</span> [<a href="/pubmed/9831343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9831343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.downey.2006.1163">Downey LM, Bottomley HM, Sheridan E, Ahmed M, Gilmour DF, Inglehearn CF, Reddy A, Agrawal A, Bradbury J, Toomes C. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. <span><span class="ref-journal">Br J Ophthalmol. </span>2006;<span class="ref-vol">90</span>:1163–7.</span> [<a href="/pmc/articles/PMC1857417/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1857417</span></a>] [<a href="/pubmed/16929062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16929062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.downey.2001.778">Downey LM, Keen TJ, Roberts E, Mansfield DC, Bamashmus M, Inglehearn CF. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:778–81.</span> [<a href="/pmc/articles/PMC1274490/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274490</span></a>] [<a href="/pubmed/11179025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11179025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.drenser.2006">Drenser KA. Pharmacologic therapy for pediatric retinal vascular disease. Las Vegas, NV: The Annual Meeting of the American Academy of Ophthalmology; 2006.</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.drenser.2009.1649">Drenser KA, Dailey W, Vinekar A, Dalal K, Capone A Jr, Trese MT. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. <span><span class="ref-journal">Arch Ophthalmol. </span>2009;<span class="ref-vol">127</span>:1649–54.</span> [<a href="/pubmed/20008721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20008721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.gong.2001.513">Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. <span><span class="ref-journal">Cell. </span>2001;<span class="ref-vol">107</span>:513–23.</span> [<a href="/pubmed/11719191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11719191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.he.2004.1663">He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. <span><span class="ref-journal">Development. </span>2004;<span class="ref-vol">131</span>:1663–77.</span> [<a href="/pubmed/15084453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15084453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.huang.2004.234">Huang HC, Klein PS. The Frizzled family: receptors for multiple signal transduction pathways. <span><span class="ref-journal">Genome Biol. </span>2004;<span class="ref-vol">5</span>:234.</span> [<a href="/pmc/articles/PMC463283/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC463283</span></a>] [<a href="/pubmed/15239825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15239825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.jia.2010.1341">Jia LY, Li XX, Yu WZ, Zeng WT, Liang C. Novel frizzled-4 gene mutations in chinese patients with familial exudative vitreoretinopathy. <span><span class="ref-journal">Arch Ophthalmol. </span>2010;<span class="ref-vol">128</span>:1341–9.</span> [<a href="/pubmed/20938005" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20938005</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.jiao.2004.878">Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:878–84.</span> [<a href="/pmc/articles/PMC1182117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182117</span></a>] [<a href="/pubmed/15346351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15346351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.junge.2009.299">Junge HJ, Yang S, Burton JB, Paes K, Shu X, French DM, Costa M, Rice DS, Ye W. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. <span><span class="ref-journal">Cell. </span>2009;<span class="ref-vol">139</span>:299–311.</span> [<a href="/pubmed/19837033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19837033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.kaykas.2004.52">Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT. Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. <span><span class="ref-journal">Nat Cell Biol. </span>2004;<span class="ref-vol">6</span>:52–8.</span> [<a href="/pubmed/14688793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14688793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.kondo.2003.1291">Kondo H, Hayashi H, Oshima K, Tahira T, Hayashi K. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. <span><span class="ref-journal">Br J Ophthalmol. </span>2003;<span class="ref-vol">87</span>:1291–5.</span> [<a href="/pmc/articles/PMC1920788/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1920788</span></a>] [<a href="/pubmed/14507768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14507768</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.kondo.2011.1095">Kondo H, Kusaka S, Yoshinaga A, Uchio E, Tawara A, Hayashi K, Tahira T. Mutations in the TSPAN12 gene in Japanese patients with familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Ophthalmol. </span>2011;<span class="ref-vol">151</span>:1095–1100.</span> [<a href="/pubmed/21334594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21334594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.little.2002.11">Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:11–9.</span> [<a href="/pmc/articles/PMC419982/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC419982</span></a>] [<a href="/pubmed/11741193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11741193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.macdonald.2005.363">MacDonald ML, Goldberg YP, Macfarlane J, Samuels ME, Trese MT, Shastry BS. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">67</span>:363–6.</span> [<a href="/pubmed/15733276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15733276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.miyakubo.1984.1524">Miyakubo H, Hashimoto K, Miyakubo S. Retinal vascular pattern in familial exudative vitreoretinopathy. <span><span class="ref-journal">Ophthalmology. </span>1984;<span class="ref-vol">91</span>:1524–30.</span> [<a href="/pubmed/6084219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6084219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.nallathambi.2006.1086">Nallathambi J, Shukla D, Rajendran A, Namperumalsamy P, Muthulakshmi R, Sundaresan P. Identification of novel FZD4 mutations in Indian patients with familial exudative vitreoretinopathy. <span><span class="ref-journal">Mol Vis. </span>2006;<span class="ref-vol">12</span>:1086–92.</span> [<a href="/pubmed/17093393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17093393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.nikopoulos.2010a.240">Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA, Arts P, Wieskamp N, Strom TM, Ayuso C, Tilanus MA, Bouwhuis S, Mukhopadhyay A, Scheffer H, Hoefsloot LH, Veltman JA, Cremers FP, Collin RW. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2010a;<span class="ref-vol">86</span>:240–7.</span> [<a href="/pmc/articles/PMC2820179/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2820179</span></a>] [<a href="/pubmed/20159111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.nikopoulos.2010b.656">Nikopoulos K, Venselaar H, Collin RW, Riveiro-Alvarez R, Boonstra FN, Hooymans JM, Mukhopadhyay A, Shears D, van Bers M, de Wijs IJ, van Essen AJ, Sijmons RH, Tilanus MA, van Nouhuys CE, Ayuso C, Hoefsloot LH, Cremers FP. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. <span><span class="ref-journal">Hum Mutat. </span>2010b;<span class="ref-vol">31</span>:656–66.</span> [<a href="/pubmed/20340138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20340138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.ober.1980.112">Ober RR, Bird AC, Hamilton AM, Sehmi K. Autosomal dominant exudative vitreoretinopathy. <span><span class="ref-journal">Br J Ophthalmol. </span>1980;<span class="ref-vol">64</span>:112–120.</span> [<a href="/pmc/articles/PMC1039360/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1039360</span></a>] [<a href="/pubmed/7362811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7362811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.omoto.2004.81">Omoto S, Hayashi T, Kitahara K, Takeuchi T, Ueoka Y. Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R). <span><span class="ref-journal">Ophthalmic Genet. </span>2004;<span class="ref-vol">25</span>:81–90.</span> [<a href="/pubmed/15370539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15370539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.poulter.2010.248">Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey DA, Kearns LS, Ruddle JB, Craig JE, Pierce EA, Downey LM, Mohamed MD, Markham AF, Inglehearn CF, Toomes C. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:248–53.</span> [<a href="/pmc/articles/PMC2820188/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2820188</span></a>] [<a href="/pubmed/20159112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.qin.2005.104">Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">26</span>:104–12.</span> [<a href="/pubmed/15981244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15981244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.robitaille.2002.326">Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">32</span>:326–30.</span> [<a href="/pubmed/12172548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12172548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.robitaille.2011.574">Robitaille JM, Zheng B, Wallace K, Beis MJ, Tatlidil C, Yang J, Sheidow TG, Siebert L, Levin AV, Lam WC, Arthur BW, Lyons CJ, Jaakkola E, Tsilou E, Williams CA, Weaver RG Jr, Shields CL, Guernsey DL. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. <span><span class="ref-journal">Br J Ophthalmol. </span>2011;<span class="ref-vol">95</span>:574–9.</span> [<a href="/pubmed/21097938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21097938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.shastry.1997.217">Shastry BS, Trese MT. Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">69</span>:217–8.</span> [<a href="/pubmed/9056564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9056564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.shastry.2004.79">Shastry BS, Trese MT. Cosegregation of two unlinked mutant alleles in some cases of autosomal dominant familial exudative vitreoretinopathy. <span><span class="ref-journal">Eur J Hum Genet. </span>2004;<span class="ref-vol">12</span>:79–82.</span> [<a href="/pubmed/14560311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14560311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.shukla.2003.323">Shukla D, Singh J, Sudheer G, Soman M, John RK, Ramasamy K, Perumalsamy N. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. <span><span class="ref-journal">Indian J Ophthalmol. </span>2003;<span class="ref-vol">51</span>:323–8.</span> [<a href="/pubmed/14750620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14750620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.tasman.1981.211">Tasman W, Augsburger JJ, Shields JA, Caputo A, Annesley WH Jr. Familial exudative vitreoretinopathy. <span><span class="ref-journal">Trans Am Ophthalmol Soc. </span>1981;<span class="ref-vol">79</span>:211–26.</span> [<a href="/pmc/articles/PMC1312184/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1312184</span></a>] [<a href="/pubmed/7342402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7342402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.toomes.2004a.721">Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GC, Downey LM, Zhang K, Inglehearn CF. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. <span><span class="ref-journal">Am J Hum Genet. </span>2004a;<span class="ref-vol">74</span>:721–30.</span> [<a href="/pmc/articles/PMC1181948/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181948</span></a>] [<a href="/pubmed/15024691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15024691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.toomes.2004b.2083">Toomes C, Bottomley HM, Scott S, Mackey DA, Craig JE, Appukuttan B, Stout JT, Flaxel CJ, Zhang K, Black GC, Fryer A, Downey LM, Inglehearn CF. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2004b;<span class="ref-vol">45</span>:2083–90.</span> [<a href="/pubmed/15223780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15223780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.van_nouhuys.1982.1">van Nouhuys CE. Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina. <span><span class="ref-journal">Doc Ophthalmol. </span>1982;<span class="ref-vol">54</span>:1–414.</span> [<a href="/pubmed/6897033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6897033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.van_nouhuys.1991.34">van Nouhuys CE. Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Ophthalmol. </span>1991;<span class="ref-vol">111</span>:34–41.</span> [<a href="/pubmed/1985487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1985487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.van_wesenbeeck.2003.763">Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:763–71.</span> [<a href="/pmc/articles/PMC1180253/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180253</span></a>] [<a href="/pubmed/12579474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12579474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.xu.2004.883">Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, Nathans J. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. <span><span class="ref-journal">Cell. </span>2004;<span class="ref-vol">116</span>:883–95.</span> [<a href="/pubmed/15035989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15035989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fevr.REF.ye.2010.417">Ye X, Wang Y, Nathans J. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. <span><span class="ref-journal">Trends Mol Med. </span>2010;<span class="ref-vol">16</span>:417–25.</span> [<a href="/pmc/articles/PMC2963063/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2963063</span></a>] [<a href="/pubmed/20688566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20688566</span></a>]</div></li></ul></div></div><div id="fevr.Chapter_Notes"><h2 id="_fevr_Chapter_Notes_">Chapter Notes</h2><div id="fevr.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 September 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TSPAN12</i> available clinically</div></li><li class="half_rhythm"><div>14 July 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 December 2008 (cd) Revision: clinical and prenatal testing available for mutations in <i>LRP5</i> and <i>FZD4</i>; prenatal testing available for mutations in <i>FZD4</i></div></li><li class="half_rhythm"><div>28 August 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically</div></li><li class="half_rhythm"><div>27 August 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 March 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>9 September 2004 (ct) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1147</span><span class="label">PMID: <a href="/pubmed/20301326" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301326</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fhm/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1147&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1147/?report=reader">PubReader</a></li><li><a href="/books/NBK1147/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1147" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1147" style="display:none" title="Cite this Page"><div class="bk_tt">Toomes C, Downey L. Familial Exudative Vitreoretinopathy, Autosomal Dominant. 2005 Mar 21 [Updated 2011 Sep 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1147/pdf/Bookshelf_NBK1147.pdf">PDF version of this page</a> (604K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fevr.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fevr.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fevr.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fevr.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fevr.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fevr.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fevr.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fevr.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fevr.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fevr.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fevr.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23554[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TSPAN12</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4041[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LRP5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8322[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FZD4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470160" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470160" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470160" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470160" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27486893" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy With a Novel LRP5 Mutation.</a><span class="source">[J Pediatr Ophthalmol Strabismu...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy With a Novel LRP5 Mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pefkianaki M, Hasanreisoglu M, Suchy SF, Shields CL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Ophthalmol Strabismus. 2016 Jul 30; 53:e39-42. Epub 2016 Jul 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26244290" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Molecular Characterization of FZD4, LRP5, and TSPAN12 in Familial Exudative Vitreoretinopathy.</a><span class="source">[Invest Ophthalmol Vis Sci. 2015]</span><div class="brieflinkpop offscreen_noflow">Molecular Characterization of FZD4, LRP5, and TSPAN12 in Familial Exudative Vitreoretinopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Seo SH, Yu YS, Park SW, Kim JH, Kim HK, Cho SI, Park H, Lee SJ, Seong MW, Park SS, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Invest Ophthalmol Vis Sci. 2015 Aug; 56(9):5143-51. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15370539" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R).</a><span class="source">[Ophthalmic Genet. 2004]</span><div class="brieflinkpop offscreen_noflow">Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Omoto S, Hayashi T, Kitahara K, Takeuchi T, Ueoka Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ophthalmic Genet. 2004 Jun; 25(2):81-90. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27800225" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy.</a><span class="source">[Turk J Ophthalmol. 2015]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sızmaz S, Yonekawa Y, T Trese M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Turk J Ophthalmol. 2015 Aug; 45(4):164-168. Epub 2015 Aug 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31237656" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Next-Generation Sequencing in the Familial Exudative Vitreoretinopathy-Associated Rhegmatogenous Retinal Detachment.</a><span class="source">[Invest Ophthalmol Vis Sci. 2019]</span><div class="brieflinkpop offscreen_noflow">Next-Generation Sequencing in the Familial Exudative Vitreoretinopathy-Associated Rhegmatogenous Retinal Detachment.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen C, Wang Z, Sun L, Huang S, Li S, Zhang A, Luo X, Huang L, Ding X. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Invest Ophthalmol Vis Sci. 2019 Jun 3; 60(7):2659-2666. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301326" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301326" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041635dde08911690f04aa">Familial Exudative Vitreoretinopathy, Autosomal Dominant - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Familial Exudative Vitreoretinopathy, Autosomal Dominant - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:08:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88EFBEE040D1D10000000004090178&amp;ncbi_session=CE88EFBEE0416341_1033SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1147%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1147&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1147/&amp;ncbi_pagename=Familial Exudative Vitreoretinopathy, Autosomal Dominant - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88EFBEE0416341_1033SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>